Biolinerx Stock Analysis

BioLineRx Stock Analysis Notes

The company has price-to-book (P/B) ratio of 1.59. Some equities with similar Price to Book (P/B) outperform the market in the long run. BioLineRx has Price/Earnings To Growth (PEG) ratio of 0.2. The entity recorded a loss per share of 0.45. The firm last dividend was issued on the 15th of July 2019. BioLineRx had 1:15 split on the 15th of July 2019. BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modiin, Israel. Biolinerx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people. For more info on BioLineRx please contact the company at 972 8 642 9100 or go to https://www.biolinerx.com.

BioLineRx Investment Alerts

BioLineRx Upcoming and Recent Events

BioLineRx Largest EPS Surprises

View All Earnings Estimates

BioLineRx Stock Institutional Investors

Note, although BioLineRx's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

BioLineRx Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.23 M.

BioLineRx Profitablity

The company has Profit Margin (PM) of (1.77) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.07.

Management Efficiency

BioLineRx has return on total asset (ROA) of (0.3523) % which means that it has lost $0.3523 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7194) %, meaning that it created substantial loss on money invested by shareholders. BioLineRx's management efficiency ratios could be used to measure how well BioLineRx manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.3 in 2024. Return On Capital Employed is likely to rise to -1.43 in 2024. Debt To Assets is likely to rise to 0.16 in 2024, whereas Total Assets are likely to drop slightly above 53.7 M in 2024.

Technical Drivers

As of the 25th of November, BioLineRx shows the Risk Adjusted Performance of (0.12), mean deviation of 3.93, and Standard Deviation of 6.83. BioLineRx technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

BioLineRx Price Movement Analysis

BioLineRx Outstanding Bonds

BioLineRx Predictive Daily Indicators

BioLineRx Forecast Models

BioLineRx's time-series forecasting models are one of many BioLineRx's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioLineRx's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how BioLineRx prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioLineRx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BioLineRx. By using and applying BioLineRx Stock analysis, traders can create a robust methodology for identifying BioLineRx entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. BioLineRx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. BioLineRx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

BioLineRx stock analysis indicators help investors evaluate how BioLineRx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading BioLineRx shares will generate the highest return on investment. By understating and applying BioLineRx stock analysis, traders can identify BioLineRx position entry and exit signals to maximize returns.

When running BioLineRx's price analysis, check to measure BioLineRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLineRx is operating at the current time. Most of BioLineRx's value examination focuses on studying past and present price action to predict the probability of BioLineRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLineRx's price. Additionally, you may evaluate how the addition of BioLineRx to your portfolios can decrease your overall portfolio volatility.